JAGUAR HEALTH, INC. Long-Term Debt
JAGUAR HEALTH, INC. (JAGX) had Long-Term Debt of $10.77 million as of 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2018-08-13
- 2018-06-30: Long-term Debt, Excluding Current Maturities $10.77M.
- 2018-03-31: Long-term Debt, Excluding Current Maturities $10.88M.
- 2017-12-31: Long-term Debt, Excluding Current Maturities $10.98M.
- 2017-06-30: Long-term Debt, Excluding Current Maturities $835.98K.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2018-06-30 | $10.77M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $10.88M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $10.98M 10-Q · filed 2018-08-13 |
| 2017-06-30 | $835.98K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.33M 10-Q/A · filed 2017-06-23 |
| 2016-12-31 | $1.82M 10-K · filed 2018-04-09 |
| 2016-09-30 | $2.27M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $2.69M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $3.63M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.10M 10-K · filed 2017-02-15 |
| 2015-09-30 | $4.46M 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |